A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode - Trial 2015-001221-16
Access comprehensive clinical trial information for 2015-001221-16 through Pure Global AI's free database. This phase not specified trial is sponsored by Janssen Cilag N.V./S.A and is currently status unknown. The study focuses on Schizophrenia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-001221-16
Trial Details
EU Clinical Trials Register • 2015-001221-16
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
Study Focus
Sponsor & Location
Janssen Cilag N.V./S.A
Janssen EMEA Medical Affairs
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Participants requiring treatment with mood stabilizers or antidepressants at study entry
ICD-10 Classifications
Schizophrenia
Simple schizophrenia
Schizophrenia, unspecified
Other schizophrenia
Paranoid schizophrenia
Data Source
EU Clinical Trials Register
2015-001221-16
Non-Device Trial